Results 121 to 130 of about 48,706 (299)
Lambertucci, José Roberto +2 more
openaire +4 more sources
Self-management of cancer treatment-related fatigue, nausea, vomiting and oral mucositis in Chinese cancer patients [PDF]
Background: Treatment-related symptoms continue to place a significant burden on many cancer patients. Many side effects require patients to engage in a range of self-management actions.
Lou, Yan
core
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija +6 more
wiley +1 more source
Introduction:Mucositis is a disturbing side effect of radiotherapy treatment forhead and neck cancer. To date, no effective modality for its prophylaxis and treatmenthas been found. We performed this study to evaluate the efficacy of oral zincsulphate in
Mohammad Mohammadianpanah +7 more
doaj
Intestinal mucositis, a common chemotherapy side effect, lacks effective treatments. This study evaluated the protective effect of selenium-enriched Bifidobacterium longum DD98 (SeDD98) on irinotecan-induced intestinal mucositis.
Yu-Shuang Qiu +8 more
doaj +1 more source
Efficacy of Episil® in patients with hematologic malignancies: a comparative study
Background Episil® is a nonabsorbable liquid medical material used to coat and protect the mucosa in patients with oral mucositis. A few studies have reported its efficacy in patients with head and neck cancer.
Taeko Fukutani +7 more
doaj +1 more source
Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins +6 more
wiley +1 more source
Palifermin for management of treatment-induced oral mucositis in cancer patients [PDF]
Andrei Barasch1, Joel Epstein2, Ken Tilashalski11Department of Diagnostic Sciences, University of Alabama at Birmingham, Birmingham, AL, USA; 2Department of Oral Medicine and Diagnostic Sciences and Otolaryngology/Head and Neck Surgery, University of ...
Joel Epstein +2 more
core
Summary To assess the cost‐effectiveness of blinatumomab plus chemotherapy for paediatric patients from Hong Kong public healthcare provider's perspective, a 10‐year Markov model was designed to simulate outcomes in paediatric patients with newly diagnosed standard‐risk B‐cell ALL at: (1) average risk and (2) high risk of relapse.
Mingjun Rui +7 more
wiley +1 more source
Mucositis (or Stomatitis) [PDF]
Arjun, Gupta, Howard Jack, West
openaire +2 more sources

